A. Behin, K. Hoang-xuan, and A. Carpentier, Primary brain tumours in adults, The Lancet, vol.361, issue.9354, pp.323-331, 2003.
DOI : 10.1016/S0140-6736(03)12328-8

L. Deangelis, Brain Tumors, New England Journal of Medicine, vol.344, issue.2, pp.114-123, 2001.
DOI : 10.1056/NEJM200101113440207

H. Fine, K. Dear, J. Loeffler, P. Black, and G. Canellos, Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults, Cancer, vol.64, issue.8, pp.2585-2597, 1993.
DOI : 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S

L. Stewart, Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials, Lancet, vol.359, pp.1011-1018, 2002.

R. Stupp, W. Mason, and M. Van-den-bent, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

D. Larson and W. Wara, Radiotherapy of primary malignant brain tumors, Seminars in Surgical Oncology, vol.14, issue.1, pp.34-42, 1998.
DOI : 10.1002/(SICI)1098-2388(199801/02)14:1<34::AID-SSU5>3.3.CO;2-2

P. Beauchesne, Three-Times Daily Ultrafractionated Radiation Therapy, A Novel and Promising Regimen for Glioblastoma Patients, Cancers, vol.5, issue.4, pp.1199-1211, 2013.
DOI : 10.3390/cancers5041199

M. Joiner, J. Denekamp, and R. Maughan, The Use of ???Top-up??? Experiments to Investigate the Effect of Very Small Doses Per Fraction in Mouse Skin, International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, vol.8, issue.4, pp.565-580, 1986.
DOI : 10.1080/09553008514552811

M. Joiner, B. Marples, and P. Lambin, Low-dose hypersensitivity: current status and possible mechanisms, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.2, pp.379-389, 2001.
DOI : 10.1016/S0360-3016(00)01471-1

P. Lambin, E. Malaise, and M. Joiner, The effect of very low radiation doses on the human bladder carcinoma cell line RT112, Radiotherapy and Oncology, vol.32, issue.1, pp.63-72, 1994.
DOI : 10.1016/0167-8140(94)90450-2

B. Chauffert, L. Feuvret, and F. Bonnetain, Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF, Annals of Oncology, vol.25, issue.7, pp.1442-1447, 2014.
DOI : 10.1093/annonc/mdu148

O. Chinot, W. Wick, and W. Mason, Bevacizumab plus Radiotherapy???Temozolomide for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.709-722, 2014.
DOI : 10.1056/NEJMoa1308345
URL : http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-89503

M. Gilbert, J. Dignam, and T. Armstrong, A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.699-708, 2014.
DOI : 10.1056/NEJMoa1308573